Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A NEXGEL, INC. Filed by: Asymmetry Point LP

April 29, 2026 10:52 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage ownership is calculated based on 8,475,693 shares of Common Stock of NexGel, Inc. ("Issuer") as of March 31, 2026, as reported in the Annual Report on Form 10-K for the year ended December 31, 2025, filed by the Issuer with the SEC on March 31, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Asymmetry Point Capital LLC is the General Partner of Asymmetry Point LP and may be deemed to have sole voting and dispositive power over the 745,000 Shares held by Asymmetry Point LP. Percentage ownership is calculated based on 8,475,693 shares of Common Stock of NexGel, Inc. ("Issuer") as of March 31, 2026, as reported in the Annual Report on Form 10-K for the year ended December 31, 2025, filed by the Issuer with the SEC on March 31, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: As the fund manager of Asymmetry Point LP and the President and Secretary of Asymmetry Point Capital LLC, the General Partner of Asymmetry Point LP, Mr. Aviv Argaman may be deemed to have sole voting and dispositive power over the 745,000 Shares held by Asymmetry Point LP. Percentage ownership is calculated based on 8,475,693 shares of Common Stock of NexGel, Inc. ("Issuer") as of March 31, 2026, as reported in the Annual Report on Form 10-K for the year ended December 31, 2025, filed by the Issuer with the SEC on March 31, 2026.


SCHEDULE 13G



Asymmetry Point LP
Signature:/s/ Asymmetry Point LLC
Name/Title:General Partner
Date:04/29/2026
Signature:/s/ Aviv Argaman
Name/Title:President and Secretary
Date:04/29/2026
Asymmetry Point Capital LLC
Signature:/s/ Aviv Argaman
Name/Title:President and Secretary
Date:04/29/2026
Mr. Aviv Argaman
Signature:/s/ Mr. Aviv Argraman
Name/Title:Aviv Argaman
Date:04/29/2026
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement, dated March 12, 2025 (incorporated by reference to Exhibit A of Schedule 13G filed with the SEC on March 12, 2026).

Categories

SEC Filings